EX-10.19 3 dex1019.htm CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENTConsultation and Scientific Advisory Board Agreement • May 5th, 2020 • Massachusetts
THIS CONSULTING AND SCIENTIFIC ADVISORY BOARD AGREEMENT effective as of this 1ST day of January, 2010 (the “Effective Date”), between AVEO PHARMACEUTICALS, INC., a Delaware corporation with offices at 75 Sidney Street, 4th Floor, Cambridge, MA 02139 (the “Company”) and Lynda Chin, MD residing at 89 Hyslop Rd, Brookline, MA 02445 (“Consultant”).
CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENTConsultation and Scientific Advisory Board Agreement • April 11th, 2012 • OvaScience, Inc. • Massachusetts
THIS CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT (the “Agreement”), dated as of 7th Sept., 2011 (the “Effective Date”), is made between OVASCIENCE, Inc., a Delaware corporation, and its successors, subsidiaries and affiliates (collectively, the “Company”), and David Sinclair (“Consultant”).
CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENTConsultation and Scientific Advisory Board Agreement • April 11th, 2012 • OvaScience, Inc. • Massachusetts
THIS CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT (the “Agreement”), dated as of 13 July 2011 (the “Effective Date”), is made between OVASCIENCE, Inc., a Delaware corporation, and its successors, subsidiaries and affiliates (collectively, the “Company”), and Jonathan Tilly (“Consultant”).
EXHIBIT 10.4 CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT This Agreement, effective as of March 10, 1995, is between Inspire Pharmaceuticals, Inc. (the "Company"), a Delaware corporation, and Richard Boucher, M.D. ("Consultant"). W I T N E S S...Consultation and Scientific Advisory Board Agreement • February 25th, 2000 • Inspire Pharmaceuticals Inc • North Carolina
